Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3048 results

Sort By:

REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)

Study ID: NCT07006935
Start Date: 2026-04-01
End Date: 2028-01-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Clubhouse Model of Psychosocial Rehabilitation for Serious Mental Illness

Usual Community-Based Mental Health Care

Sponsor

Case Western Reserve University

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

Study ID: NCT07137338
Start Date: 2026-06
End Date: 2029-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

8

Intervention / Treatment

RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, BCL2-associated Athanogene 3 (BAG3)

Sponsor

Rocket Pharmaceuticals Inc.

Source: clinicaltrials.gov

Share:
Add to list

Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment

Study ID: NCT07210606
Start Date: 2026-10-01
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

200

Intervention / Treatment

Trazodone + PAP therapy

Oxygen + PAP therapy

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

Study ID: NCT06965504
Start Date: 2026-04-01
End Date: 2029-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Impella 5.5 SmartAssist

Sponsor

Abiomed Inc.

Source: clinicaltrials.gov

Share:
Add to list

Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial

Study ID: NCT06274749
Start Date: 2026-03-10
End Date: 2027-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

Urolithin A

Placebo

Sponsor

National Institute on Aging (NIA)

Source: clinicaltrials.gov

Share:
Add to list

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer

Study ID: NCT07427186
Start Date: 2026-04-15
End Date: 2041-04-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

Patients treated with immune checkpoint blockade in neo-adjuvant setting and possibly in adjuvant setting (if applicable)

Sponsor

Institut Claudius Regaud

Source: clinicaltrials.gov

Share:
Add to list

Overdose Prevention Centers and Behavioral Health

Study ID: NCT06236087
Start Date: 2026-09-01
End Date: 2027-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment
Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list

SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules

Study ID: NCT06775587
Start Date: 2026-04-08
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Serum Raman spectroscopy intelligent diagnostic system

Sponsor

Fuzhou General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder

Study ID: NCT06934915
Start Date: 2026-11
End Date: 2029-02
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

32

Intervention / Treatment

Prednisone

Placebo

Sponsor

Christopher John McDougle, M.D.

Source: clinicaltrials.gov

Share:
Add to list

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Study ID: NCT06667726
Start Date: 2026-05-01
End Date: 2029-10-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

47

Intervention / Treatment

Computed Tomography

Fluorodopa F 18

Positron Emission Tomography

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list